Incidence and prognostic significance of atrial fibrillation in acute myocardial infarction: the GISSI-3 data

被引:235
作者
Pizzetti, F
Turazza, FM
Franzosi, MG
Barlera, S
Ledda, A
Maggioni, AP
Santoro, L
Tognoni, G
机构
[1] Mario Negri Inst Pharmacol Res, Dept Cardiovasc Res, GISSI Coordinating Ctr, I-20157 Milan, Italy
[2] S Spirito Hosp, Div Cardiol, Casale Monferrato, AL, Italy
[3] Cervello Hosp, Div Cardiol, Palermo, Italy
[4] ANMCO, Ctr Studi, Florence, Italy
关键词
atrial fibrillation; acute myocardial infarction; prognosis;
D O I
10.1136/heart.86.5.527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Atrial fibrillation is the most common supraventricular arrhythmia in patients with acute myocardial infarction. Recent advances in pharmacological treatment of myocardial infarction may have changed the impact of this arrhythmia. Objective-To assess the incidence and prognosis of atrial fibrillation complicating myocardial infarction in a large population of patients receiving optimal treatment, including angiotensin converting enzyme (ACE) inhibitors. Methods-Data were derived from the GISSI-3 trial, which included 17 944 patients within the first 24 hours after acute myocardial infarction. Atrial fibrillation was recorded during the hospital stay, and follow up visits were planned at six weeks and six months. Survival of the patients at four years was assessed through census offices. Results-The incidence of in-hospital atrial fibrillation or flutter was 7.8%. Atrial fibrillation was associated with indicators of a worse prognosis (age > 70 years, female sex, higher Killip class, previous myocardial infarction, treated hypertension, high systolic blood pressure at entry, insulin dependent diabetes, signs or symptoms of heart failure) and with some adverse clinical events (reinfarction, sustained ventricular tachycardia, ventricular fibrillation). After adjustment for other prognostic factors, atrial fibrillation remained an independent predictor of increased in-hospital mortality: 12.6% v 5%, adjusted relative risk (RR) 1.98, 95% confidence interval (CI) 1.67 to 2.34. Data on long term mortality (four years after acute myocardial infarction) confirmed the persistent negative influence of atrial fibrillation (RR 1.78, 95% CI 1.60 to 1.99). Conclusions-Atrial fibrillation is an indicator of worse prognosis after acute myocardial infarction, both in the short term and in the long term, even in an unselected population.
引用
收藏
页码:527 / 532
页数:6
相关论文
共 31 条
[1]   ATRIAL-FIBRILLATION AND FLUTTER AS A COMPLICATION OF ACUTE MYOCARDIAL-INFARCTION [J].
BECK, OA ;
HOCHREIN, H .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1976, 101 (31) :1148-1153
[2]   LONG-TERM PROGNOSIS OF PATIENTS WITH PAROXYSMAL ATRIAL-FIBRILLATION COMPLICATING ACUTE MYOCARDIAL-INFARCTION [J].
BEHAR, S ;
ZAHAVI, Z ;
GOLDBOURT, U ;
REICHERREISS, H ;
NEUFELD, HN ;
AGMON, J ;
BEHAR, S ;
GOLDBOURT, U ;
REICHERREISS, H ;
ABINADER, E ;
BARZILAY, J ;
FRIEDMAN, Y ;
KAULI, N ;
KISHON, Y ;
PALANT, A ;
PELED, B ;
REISIN, L ;
RISS, E ;
SCHLESINGER, Z ;
ZAHAVI, I ;
ZION, M .
EUROPEAN HEART JOURNAL, 1992, 13 (01) :45-50
[3]  
BERISSO MZ, 1988, ACTA CARDIOL, V43, P689
[4]  
COX DR, 1972, J R STAT SOC B, V34, P187
[5]   Atrial fibrillation in the setting of acute myocardial infarction: The GUSTO-I experience [J].
Crenshaw, BS ;
Ward, SR ;
Granger, CB ;
Stebbins, AL ;
Topol, EJ ;
Califf, RM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (02) :406-413
[6]   ATRIAL-FIBRILLATION DEVELOPING IN ACUTE PHASE OF MYOCARDIAL-INFARCTION - PROGNOSTIC IMPLICATIONS [J].
CRISTAL, N ;
PETERBURG, I ;
SZWARCBERG, J .
CHEST, 1976, 70 (01) :8-11
[7]   SUPRAVENTRICULAR ARRHYTHMIAS IN ACUTE MYOCARDIAL-INFARCTION - PROGNOSTIC IMPORTANCE OF CLINICAL SETTING - MECHANISM OF PRODUCTION [J].
CRISTAL, N ;
SZWARCBERG, J ;
GUERON, M .
ANNALS OF INTERNAL MEDICINE, 1975, 82 (01) :35-39
[8]  
DEVITA C, 1994, LANCET, V343, P1115
[9]  
FLUGELMAN MY, 1986, ISRAEL J MED SCI, V22, P355
[10]   Indications for ACE inhibitors in the early treatment of acute myocardial infarction -: Systematic overview of individual data from 100,000 patients in randomized trials [J].
Franzosi, MG ;
Santoro, E ;
Zuanetti, G ;
Baigent, C ;
Collins, R ;
Flather, M ;
Kjekshus, J ;
Latini, R ;
Liu, LS ;
Maggioni, AP ;
Sleight, P ;
Swedberg, K ;
Tognoni, G ;
Yusuf, S ;
Tavazzi, L ;
Ball, S ;
Kober, L ;
Torp-Pedersen, C ;
Braunwald, E ;
Moyé, L ;
Pfeffer, M ;
Santoro, L ;
Pogue, J ;
Wang, Y .
CIRCULATION, 1998, 97 (22) :2202-2212